| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/04/2006 | EP1610811A2 Prevention and treatment of cardiac arrhythmias |
| 01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
| 01/04/2006 | EP1610805A2 Thiol-mediated drug attachment to targeting peptides |
| 01/04/2006 | EP1610804A2 Igf-binding protein-derived peptide or small molecule |
| 01/04/2006 | EP1610802A2 Parkin interacting polypeptides and methods of use |
| 01/04/2006 | EP1610757A2 Profiling conformational variants, antibody compositions and methods of using the same |
| 01/04/2006 | EP1534744A4 Altered insulin-like growth factor binding proteins |
| 01/04/2006 | EP1474516A4 Methods of modulating cold sensory perception |
| 01/04/2006 | EP1411121B1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1278867B1 Hcv ns2/3 fragments and uses thereof |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1169642B1 Complex formed by n-linked glycoproteins (siblings) and factor h |
| 01/04/2006 | EP1053325B1 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 01/04/2006 | EP1005542B1 APOLIPOPROTEIN E TRANSGENIC mice AND ASSAY METHODS |
| 01/04/2006 | EP0966545B1 Method for typing of minor histocompatibility antigen ha-1 |
| 01/04/2006 | EP0927255B1 Vaccine production of the bacillus anthracis protective antigen |
| 01/04/2006 | EP0923606B1 Antigenic fusionprotein carrying galalpha1,3gal epitopes |
| 01/04/2006 | EP0804609B1 NOVEL p53 RESPONSE GENES |
| 01/04/2006 | EP0668931B1 Nucleic acid ligands and methods for producing the same |
| 01/04/2006 | CN1717587A Methods of protecting against radiation damage using alpha thymosin |
| 01/04/2006 | CN1717485A Soluble NOTCH-based substrates for gamma secretase and methods and compositions for using same |
| 01/04/2006 | CN1717476A Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 01/04/2006 | CN1717417A Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases |
| 01/04/2006 | CN1717416A Hepatisis C virus nonstructural protein 4A (NS4A) is an enhancer element |
| 01/04/2006 | CN1717413A Novel PTH responsive gene |
| 01/04/2006 | CN1717249A Prekallikrein depleted plasma derived albumin fraction |
| 01/04/2006 | CN1715926A Neuregulin mutant, screening method and use |
| 01/04/2006 | CN1715915A Molecular detection method for fusarium toxin |
| 01/04/2006 | CN1715414A Genes for the biosynthesis of epothilones |
| 01/04/2006 | CN1715413A Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2006 | CN1715412A Gene relative to cotton fiber development and its coded protein and use |
| 01/04/2006 | CN1715411A Salt resistant and drought resistant gene of Thellugielkla halophila and its coded protein and use |
| 01/04/2006 | CN1715410A Clone of duckwheat allergic storage protein gene and its use |
| 01/04/2006 | CN1715409A Process for preparing medicine grade recombined human urine trypase inhibitor |
| 01/04/2006 | CN1715296A Recombinant human mannan-binding lectin |
| 01/04/2006 | CN1714863A Method for extracting curcin and its use |
| 01/04/2006 | CN1234870C Novel miniature inverted-repeat transposable elements (MITE)-like element and transcriptional activation element |
| 01/04/2006 | CN1234867C Novel bacillus thuringiensis insecticidal proteins |
| 01/04/2006 | CN1234729C Protein cross linking agent and method therefor |
| 01/04/2006 | CN1234728C Novel human lymphokine, its coding sequence and use |
| 01/04/2006 | CN1234727C Human thymosin alpha protogene mutant synthesis, expression and use |
| 01/04/2006 | CN1234726C Nucleic acid sequence, expression carrier and application of steady wheat high molecular gluten Dtx1.5 subunit coding gene |
| 01/04/2006 | CN1234720C Detection systems for registering protein interactions and functional relationships |
| 01/04/2006 | CN1234411C Anti-tumor medicine |
| 01/03/2006 | US6982371 improved herbicide/insect/disease resistance; horticulture |
| 01/03/2006 | US6982363 UDP-glucose modifiers |
| 01/03/2006 | US6982362 for diagnosis/treatment of arteriosclerosis, diabetes; stem cells |
| 01/03/2006 | US6982326 Allergenic proteins and peptides from Japanese cedar pollen |
| 01/03/2006 | US6982323 Chimeric proteins for diagnosis and treatment of diabetes |
| 01/03/2006 | US6982320 Cytokine receptor common gamma chain like |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982317 C21 polypeptide that modulates the stability of transcriptional regulatory complexes regulating nuclear hormone receptor activity |
| 01/03/2006 | US6982316 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 01/03/2006 | US6982314 Lawsonia intracellularis proteins, and related methods and materials |
| 01/03/2006 | US6982313 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs |
| 01/03/2006 | US6982250 Methods of prevention and treatment of inflammatory bowel disease |
| 01/03/2006 | US6982247 isolated peptide or protein of given sequence derived from the mucus of the foot sole of Archachatina marginata, a West-African snail; use against viral, bacterial or fungal infections |
| 01/03/2006 | US6982246 oligopeptides comprising a sequence associated with HLA-B alpha 1 domain, but comprising a tyrosine-tyrosine-tryptophan triad; preventing organ transplant rejection; side effect reduction so the patient can still fight infections |
| 01/03/2006 | US6982170 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1 |
| 01/03/2006 | US6982164 preferred derivatives comprise a mixture of amino acids, peptides and/or protein fractions derived from the extraction and optional hydrolysis of naturally occurring jojoba protein; use in cosmetics and as extenders |
| 01/03/2006 | US6982162 Genetically engineered microorgaism for use as diagnostic tool |
| 01/03/2006 | US6982156 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines |
| 01/03/2006 | US6982154 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease |
| 01/03/2006 | US6982153 DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides |
| 01/03/2006 | US6982149 Fiber array and methods for using and making same |
| 01/03/2006 | US6982148 Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis |
| 01/03/2006 | US6982087 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 01/03/2006 | US6982086 Human immunodeficiency virus immunogenic composition |
| 01/03/2006 | US6982085 Induce antibody response; drugs, medical diagnosis |
| 01/03/2006 | US6982084 An immunogenic A beta fragment linked to a carrier molecule to form a conjugate, wherein the carrier molecule promotes an immune response comprising antibodies to the A beta fragment; Alzheimer's disease; antibodies |
| 01/03/2006 | CA2329510C Promoter sequence which is expressed in anthers and in pollen |
| 01/03/2006 | CA2261314C Frozen food with antifreeze peptides |
| 01/03/2006 | CA2162586C Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 01/03/2006 | CA2158937C Recombinant alphavirus vectors |
| 01/03/2006 | CA2070979C Sequence specific dna binding by p53 |
| 01/01/2006 | CA2502425A1 Allergen from house-dust mites |
| 12/30/2005 | CA2511084A1 Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications |
| 12/29/2005 | WO2005124341A2 Stable isotope labeled polypeptide standards for protein quantitation |
| 12/29/2005 | WO2005123958A2 Cd7 as biomarker and therapeutic target for psoriasis |
| 12/29/2005 | WO2005123935A1 Method of producing therapeutically useful product and system |
| 12/29/2005 | WO2005123929A2 Plastid transit peptides |
| 12/29/2005 | WO2005123923A2 Inducer specific tetracycline repressor proteins and methods of use thereof |
| 12/29/2005 | WO2005123920A1 Anther specific promoters and uses thereof |
| 12/29/2005 | WO2005123917A1 Stabilized proline transporter |
| 12/29/2005 | WO2005123778A2 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 12/29/2005 | WO2005123776A1 Methods for treating conditions associated with lectin-dependent complement activation |
| 12/29/2005 | WO2005123775A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 12/29/2005 | WO2005123771A2 Oligomeric peptides and their use for the treatment of hiv infections |
| 12/29/2005 | WO2005123770A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 12/29/2005 | WO2005123769A1 Hla-a2-binding protein originating in prostate-related antigen |
| 12/29/2005 | WO2005123768A1 Peptide-based compounds |
| 12/29/2005 | WO2005123767A1 Peptide-based compounds |
| 12/29/2005 | WO2005123766A2 Methods of making nanotechnological and macromolecular biomimetic structures |
| 12/29/2005 | WO2005123765A1 Process for producing active wnt proteins in prokaryotes |
| 12/29/2005 | WO2005123764A1 Preparation of protective antigen from bacillus anthracis |
| 12/29/2005 | WO2005123763A1 Production of polypeptides by improved secretion |
| 12/29/2005 | WO2005123762A2 Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
| 12/29/2005 | WO2005123759A2 Fgfr binding peptides |